Article

Timothy Stout named BCM ophthalmology chairman

Baylor College of Medicine (BCM) has named Timothy Stout, MD, PhD, as its new ophthalmology department chairman.

 

Houston-Baylor College of Medicine (BCM) has named Timothy Stout, MD, PhD, as its new ophthalmology department chairman.

A graduate of BCM, Dr. Stout had been serving as vice president for commercialization strategies and as a professor of ophthalmology and molecular genetics at Oregon Health and Sciences University.

“With a proven track record and excellent leadership skills, Dr. Tim Stout is the ideal choice to chair the ophthalmology department,” said Paul E. Klotman, MD, president and chief executive officer of BCM. “He understands BCM and our strategic vision for the future in patient care, research, and education.”

Dr. Stout received both his medical degree and doctorate from BCM. His appointment is effective in December, as he will succeed Dan Jones, MD, who is retiring after serving as chairman for more than 30 years.

“I’m very much looking forward to returning home to Baylor and the Cullen Eye Institute,” Dr. Stout said. “Danny Jones has set an incredible standard and I look forward to helping shape the future of the department.”

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.